top of page

Kapchorua Tea Kenya plc: June 2026 Analysis

  • Jun 12
  • 7 min read

Executive Summary

Kapchorua Tea (NSE: KAPC) is a small, illiquid Kenyan tea producer that enjoyed a sharp rebound in HY2026 earnings after a weak FY2025. Revenue in FY2025 was flat at KES 2.22 billion, but net profit plunged ~55% to KES 181.2 million (EPS KES 23.16). By contrast, HY2026 (Sept. 2025) delivered KES 95.2 m profit on KES 829.9 m sales (EPS KES 12.17), up 5× thanks to cost cuts and a

KES 39.4 m non-cash biological-asset gain. Cash flow from operations has been very strong (KSh 287.8 m in HY2026) despite lower sales.

However, much of the profit recovery hinges on gains in the fair value of timber and fuel trees (biological assets) and cost savings, raising questions about earnings quality. The company still paid a KES 25/share final dividend for FY2025 (KES 117.4 m total), and declared KES 195.6 m for HY2026 (after a 1:1 bonus share issue, this is KES 12.50/share). This yields ~4.5% at today’s price.

We find that the market seems to be pricing a continuation of these improved results. Our base‐case fair value (~KES 300/sh) is modestly above the current ~KES 275/sh price, reflecting a cautiously optimistic view of tea volumes/prices and cost management. Recommendation: HOLD. One-year target ~KES 300. Upside catalysts include sustained price support and cost control; downside risks include falling auction prices, drought impacting output, and rising input costs. We watch next results for realized tea prices, production volumes, and cash flow trends.

Company Snapshot

  • Business: Kapchorua Tea Kenya Plc (NSE:KAPC) is a tea estate, factory and branded tea producer. It grows and processes tea at its Nandi Hills estate and sells mainly via the Mombasa Auction. The company also holds timber/fuel tree plantations (biological assets).

  • Scale: Formerly listed with 7.824 m shares, Kapchorua completed a 1-for-1 bonus share issue in Oct 2025. The enlarged share count is now 15.648 m shares, making the stock very small (market cap ~KES 4.3 bn) and illiquid (avg. monthly turnover ~KES 7.9 m).

  • History/Ownership: Founded 1869, Kapchorua is a subsidiary of Williamson Tea (UK). It has steadily modernized its factory (completed expansion by 2024) and sources green leaf from both its own estate (~2.2 m kg in 2024) and smallholders (~6.5 m kg).

  • Products & Operations: All revenue comes from tea production and sales (there is no other segment). Output ~8–9 m kg/year (record 2024 output of 8.69 m kg). Key drivers: auction prices (now ~$1.00–1.10/kg in USD), yield/volume (rainfall-dependent), fertilizer and fuel costs, and the forex rate (weaker KES boosts export revenue). Profits also include fair-value gains on biological assets (timber/fuel trees), which can swing earnings.

Forward Outlook & Catalysts

  • Tea Prices & Demand: Global tea demand is stable, but Kenyan auctions face oversupply. April 2026 price index ~$1.03/kg was ~6% below last year. If prices recover (e.g. due to El Niño rains boosting quality or new markets), Kapchorua’s revenue would benefit. Conversely, continued weak prices or greater export competition could hurt. The company noted “Kenyan tea continuing to outstrip global demand”.

  • Weather/Rainfall: Tea yields critically depend on rains. Early-2025 drought cut production ~13%. If 2026 (March–May long rains) are good, volumes could rise; if dry conditions repeat, volumes will suffer. Recent forecasts (IGAD) had hinted at below-average rains.

  • Input Costs: Fertilizer, fuel and firewood costs remain high. If these input inflation continues, margins will be pressured. Any government subsidies on fertilizer or lower fuel prices would help.

  • FX: A weaker KSh benefits Kapchorua (more KSh per $1 export). The shilling has been fairly stable (USD~Ksh129–130 as of June 2026). Sharp currency changes could swing earnings.

  • Interest Rates/Macro: Kenya’s CBK held rates at 8.75% in June 2026. High interest has not directly affected Kapchorua (no debt), but influences consumer demand and inflation. Stable inflation (~6.7% May 2026) suggests no immediate cost shock.

  • Company-Specific: Key catalysts would be: Q2 and FY2026 results (production volumes, realized prices, fair-value gains), AGM decisions on dividend (likely maintained to date), and any strategic moves (new processing lines, buyer contracts). The 1:1 bonus share increased free float (now 15.65m shares), which may modestly improve trading liquidity and visibility.

  • Sector Sentiment: Teas stocks trade cautiously; Williamson Tea is still loss-making. If Kenyan tea sector sentiment improves (e.g. from higher prices or structural reforms at Tea Board), Kapchorua could rerate.

Key Risks

  • Overreliance on Non-Cash Gains: If biological asset valuations reverse (smaller fair-value gains or losses), reported profits could plummet even if operations are stable. Watch the change in “biological assets” line.

  • Tea Price Drop: A further slide in Mombasa auction prices (due to global oversupply or demand slump) would directly cut revenues. A 10% drop in $/kg without volume gains would wipe ~10% off sales.

  • Weather Variability: Droughts can sharply reduce output (as in 2025). Any setback in crop volume hits revenue and cash flow.

  • Cost Inflation: Rising fertilizer, labor, or wood costs squeeze margins. Unlike some peers, Kapchorua has limited ability to pass on costs due to thin auction margins.

  • Liquidity & Market Risk: The stock is extremely thinly traded, so it can be volatile. This also means the price may overshoot to extremes on small flows (both up and down). The new bonus shares doubled floats to ~15.65m (better than ~7.8m) but liquidity is still low.

  • High Payout Pressure: The firm’s commitment to a high dividend (KES 25 recommended again) is not backed by robust earnings yet (payout > 100% in trailing FY). If profits falter, investors must watch if management cuts the dividend – any cut could depress the stock.

  • Macroeconomic Shocks: A sudden KSh appreciation would hurt export revenue. Likewise, major forex or interest shocks could indirectly affect business confidence and credit costs (for smallholder farmers, for example).


The stock currently trades near our base-case price, so we rate it HOLD. The 9% potential upside to KSh 300 is tempered by high uncertainty. A buy would be more attractive if price dips toward ~KSh 250 with improving fundamentals, or if we see clear signs of sustained profit recovery.


Technical: Fianancial review and Vlauation summary

Financial & Operational Review

FY2025 (Mar 2024–Mar 2025)

  • Revenue: KES 2.218 bn, essentially flat (+1.1%) from KES 2.194 bn in FY2024. Volume gains (from the new factory) were offset by a weaker USD/kg tea price compared to 2024. The annual Mombasa auction index fell ~6% YoY (US$1.099/kg Mar 2024 to US$1.029/kg Apr 2026).

  • Profitability: PBT fell ~54% to KES 261.5 m and PAT to KES 181.2 m (EPS 23.16). Operating profit was only KES 111.0 m (vs KES 338.5 m prior) because of higher costs and flat volumes. A material fair-value gain on trees (KES 70.2 m pre-tax) cushioned the decline. After tax, profit was ~KES 181 m vs KES 399 m prior. Earnings per share dropped from KES 51.04 to KES 23.16.

  • Dividend: Directors proposed a KES 25/share final dividend (total KES 117.36 m) for FY2025, roughly equating to 100%+ payout. Dividend cover was only 0.93×. (After the bonus issue, this became KES 12.50/share for 2025).

  • Cash Flow: Net cash from operations was KES 302.2 m (vs KES 399.2 m in FY2024). The drop reflects higher taxes (KES 179.5 m paid) despite higher interest income (KES 56.3 m). Capex was low (KES 97.4 m) and the company financed dividends of KES 115.7 m. Cash at year-end was KES 674.1 m, up from KES 588.7 m. Overall, FY2025 CFO exceeded net profit, indicating solid conversion.

  • Balance Sheet: No significant borrowings. Inventories (unsold finished tea) actually fell sharply (KES 206.5 m from KES 455.0 m), suggesting improved stock turnover. Receivables ~KES 245.5 m. Biological assets (wood stocks) on the balance sheet rose ~21% to KES 456.0 m. Equity was KES 2.099 bn, up slightly from prior year.

HY2026 (Apr–Sep 2025)

  • Revenue: KES 829.9 m (–24.2% YoY from KES 1.093 bn in HY2025). The 2025 half suffered from weak tea prices and softer export demand.

  • Profit: Net profit KES 95.2 m, vs only KES 18.2 m year-ago, a 5× jump. This came even though sales fell sharply. Operational profit before tax turned positive to ~KES 75.2 m (vs a loss KES 5.2 m prior), driven by cutting costs. Crucially, a KES 39.4 m fair-value gain on biological assets (vs KES 7.9 m prior) inflated profits. Excluding that non-cash gain, underlying profit was about KES 55.8 m. EPS rose to KES 12.17 from KES 2.33.

  • Cash Flow: CFO was KES 287.8 m (much stronger than KES 32.5 m in H1 2024), reflecting efficient working capital management and high net interest. After KES 26.3 m capex and KES 192.4 m dividends, cash still rose KES 69.1 m. Cash at 30 Sept 2025 was KES 749.9 m (up 62% YoY). In short, cash generation was very healthy.

  • Dividend: The Board approved a KES 25/share dividend for 2025 (to pay Sept 2026), effectively KES 195.6 m total (substantially higher than KES 117.36 m prior year). Again, payout ratio exceeds current earnings.

Quality of Earnings

The rebound in profit is partly accounting-driven. The large swing in the fair-value of biological assets (wood) is purely non-cash. HY2026 saw a KES 39.4 m valuation gain; FY2025 had KES 70.2 m gain, but that was smaller than 2024’s KES 86.9 m. These swings dominate volatility in reported profit. Operating cash flows and working-capital trends are arguably more telling: both FY2025 and HY2026 generated CFO well above net profit, indicating that cash generation (from tea sales) was solid.

However, the sustainability of dividends is questionable. Dividend cover fell below 1.0× in FY2025, meaning they were paying out more than profit (using reserves). Management’s policy appears to maintain high dividends for now, but if earnings don’t recover, cover could remain <1x. The company still has sizeable cash (~KSh 750m) to help sustain payouts in the short term, but ideally earnings should rise.


Valuation Summary

We consider multiple lenses:

  • Dividend Discount (DDM): The run-rate dividend post-bonus is KES 12.50/sh (was 25 on old base). At a 10% cost of equity, PV = 12.5/0.10 = KES 125. A more optimistic 2% growth raises it to ~KES 155. These numbers are well below today’s ~KES 280 price, reflecting the low coverage. If cost of equity is lower (8%), fair value ~160–170. In short, a pure DDM yields ~KES 125–170, suggesting the current price >100% of the dividend value.

  • Normalized Earnings Valuation (DCF on CFO): Using the strong cash flow run-rate (FY2025 CFO KES 302m, HY2026 CFO KES 288m), assume stable CFO ~KSh 600m/year. After modest reinvestment, free cash might be ~KSh 500m. At 10× p/FCF, market cap ~KES 5.0 bn, or ~KES 320/sh. At 8×, ~KES 256. These ballparks (~KES 260–320) straddle current ~KES 280.

  • PE Multiple: If HY2026 profit KES 95m annualizes to ~KES 190m, EPS ~KSh 12.2 (post-bonus). Today’s price ~KES 280 gives PE ≈ 23× “trailing” HY earnings. But if FY2026 fully benefits (say PAT ~200–250m ≈ EPS KSh 25–30), a 12×–15× multiple (reasonable for a stable agriculture co.) yields target ~KES 300–450. Our base assumes EPS ~ KES 20–25 and PE ~12, i.e. KSh 240–300.

  • Comparables: Few direct peers. Limuru Tea (small) trades at mid-single-digit multiples with weaker results. Kakuzi/Sasini etc. have little relevance due to diversified crops. No strong P/E references exist; we rely on cash flows and yield.

Valuation Table (illustrative):

Method

Key Assumptions

Implied Price (KES)

Dividend Discount

DPS=KSh 12.5, g=0%, r=10%

~125

Dividend Discount

DPS=KSh 12.5, g=2%, r=10%

~155

DCF/FCF (8×)

FCF ~KSh 500m, shares=15.65m, r=10%

~256

DCF/FCF (10×)

FCF ~KSh 500m

~320

PE (x12)

EPS KSh 25 (FY2026 forecast)

~300

PE (x15)

EPS KSh 25

~375

Current Price


~KSh 280

Footnotes: Dividend yields now only ~4.5% (12.5/280). The market-implied growth (if price 280 with EPS 16.5 est.) is high. Our base-case fair value ~KSh 300 (10% above current). Bear-case (weak recovery) ~KSh 220 (roughly -20%). Bull-case (strong tea prices + stable yield) ~KSh 350+.


Comments


download (4)_edited_edited_edited.jpg

Subscribe to InvestingIQ newsletter

© 2026 by Hunnington Leo Limited. Powered and secured by Wix

bottom of page